Statistics from Altmetric.com
Bristol-Myers Squibb recently awarded a 5-year $500,000 Unrestricted Cancer Research Grant to Vall d'Hebron University Hospital in Barcelona, Spain, for research on a superfamily of tumor growth factor receptors. Called epidermal growth factor receptors, these cell surface receptors allow a particular growth factor molecule to attach to the cell and cause uncontrolled growth and division. José Baselga, MD, who pioneered the clinical application of the first “smart” drug that could attach to the growth factor receptor and block the tumor-causing molecule, …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.